WHO ICTRP trial
Effects of treatment with FOPCON in patients with Fibrodysplasia Ossificans…
RBR-9dkn9ry · Registro Brasileiro de Ensaios Clinicos (ReBEC) · Not Recruiting
Key facts
| Trial ID | RBR-9dkn9ry |
|---|---|
| Public title | Effects of treatment with FOPCON in patients with Fibrodysplasia Ossificans Progressiva |
| Scientific title | Clinical, biochemical and molecular aspects in patients with Fibrodysplasia Ossificans Progressiva before and after treatment with ascorbic acid, propranolol, hesperidine and epigallocatechin |
| Primary sponsor | Universidade Federal de Mato Grosso do Sul |
| Secondary sponsors | Instituto de Assistência e Pesquisa em Educação e Saúde - IAPES |
| Registry | Registro Brasileiro de Ensaios Clinicos (ReBEC) |
| Recruitment status | Not Recruiting |
| Study type | Intervention |
| Countries | Brazil |
| Conditions | Fibrodysplasia Ossificans Progressiva |
| Interventions | Research participants form four intervention groups. Group 2: eight people with FOP (Fibrodysplasia Ossificans Progressiva), without previous specific treatment for the disease; Group 3: eight people with FOP being treated with FOPCON… |
| Registration date | Jul 8, 2023 |
| Registry page | ensaiosclinicos.gov.br |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: